Jazz Pharmaceuticals plc - Ordinary Shares — Financial Statements (NASDAQ:JAZZ) | MetaTrader

Open full chart

News

Axsome Begins Phase III Study on Solriamfetol for ADHD in Children

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Momentum Stock: Should You Buy?

Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?

Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline

HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase

JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies

JAZZ's Zepzelca Fails to Meet Primary Goal in Lung Cancer Study

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Why Is Jazz (JAZZ) Up 1% Since Last Earnings Report?

Jazz Pharmaceuticals plc (JAZZ) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Momentum Stock